Skip to main content

Table 1 Demographic and pathologic data of adrenal tumors with myelolipomatous metaplasia

From: Adrenocortical adenoma with myelolipomatous metaplasia: a potential diagnostic pitfall: a case report and review of the literature

No. Authors Age Sex Adrenal pathology Underlying disease Other remarkable finding
1 Vyberg et al. [15] 31 F ACA
2 Parenteau et al. [16] 28 M Pigmented adrenal hyperplasia
3 Lamas et al. [17] 49 F ACA
4 Lamas et al. [17] 67 F ACA HTN/DM
5 Montone et al. [20] 50 F Adrenocortical neoplasm of UMP
6 Montone et al. [20] 56 F Adrenocortical neoplasm of UMP
7 Montone et al. [20] 67 F ACA HTN
8 Inomoto et al. [21] 46 F Black ACA HTN
9 Yamada et al. [22] 72 F ACA Chronic hepatitis C Concurrent endothelial cyst in adrenal
10 Shastri et al. [23] 40 F Oncocytoma HTN Bilateral
11 Gurbuz et al. [24] 66 M ACA Goiter surgery
Nephrectomy
12 Yokoyama et al. [25] 34 F ACC Tumor site was ectopic adrenal (retroperitoneum)
13 Chandramahanti et al. [26] 66 F ACA HTN/DM
14 Hendry et al. [27] 60 F ACA HTN/hypothyroidism Concurrent epithelioid angiosarcoma in adrenal
15 Kinebuchi et al. [28] 77 M Cavernous hemangioma History of gastric and rectal cancer
16 Dokmetas et al. [29] 53 F ACA HTN/DM Concurrent schwannoma in adrenal
17 Larose et al. [30] 61 F Macronodular adrenal hyperplasia Bilateral
18 Fırat et al. [31] 62 F ACA
19 Fırat et al. [31] 73 M ACA HTN Concurrent endothelial cyst in the adrenal
20 Current case 45 F ACA HTN
ESRD
Concurrent pancreas cyst
  1. ACA adrenocortical adenoma, ACC adrenocortical carcinoma, UMP uncertain malignant potential, HTN hypertension, DM diabetes mellitus, ESRD end-stage renal disease